The proto-oncogenic role of EGFR has been established in several types of cancers, such as non-small-cell lung cancer (NSCLC) [38], glioblastoma [39], squamous cell carcinoma of the head and neck [40], breast cancer [41], colorectal cancer [42], and pancreatic cancer [43]. This evidence concerns the gene EGFR and cancer.